vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Core Natural Resources, Inc. (CNR). Click either name above to swap in a different company.

Core Natural Resources, Inc. is the larger business by last-quarter revenue ($1.0B vs $749.2M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -7.6%, a 11.2% gap on every dollar of revenue. On growth, Core Natural Resources, Inc. posted the faster year-over-year revenue change (81.8% vs 62.0%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 38.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Arch Resources, previously known as Arch Coal, was an American coal mining and processing company. The company mined, processed, and marketed bituminous and sub-bituminous coal with low sulfur content in the United States. Arch Resources was the second-largest supplier of coal in the United States, behind Peabody Energy. As of 2011 the company supplied 15% of the domestic market. Demand came mainly from generators of electricity.

CLOV vs CNR — Head-to-Head

Bigger by revenue
CNR
CNR
1.4× larger
CNR
$1.0B
$749.2M
CLOV
Growing faster (revenue YoY)
CNR
CNR
+19.7% gap
CNR
81.8%
62.0%
CLOV
Higher net margin
CLOV
CLOV
11.2% more per $
CLOV
3.6%
-7.6%
CNR
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
38.1%
CNR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
CNR
CNR
Revenue
$749.2M
$1.0B
Net Profit
$27.3M
$-79.0M
Gross Margin
Operating Margin
3.6%
-9.3%
Net Margin
3.6%
-7.6%
Revenue YoY
62.0%
81.8%
Net Profit YoY
-356.3%
EPS (diluted)
$0.05
$-1.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
CNR
CNR
Q1 26
$749.2M
Q4 25
$487.7M
$1.0B
Q3 25
$496.6M
$1.0B
Q2 25
$477.6M
$1.1B
Q1 25
$462.3M
$1.0B
Q4 24
$337.0M
$573.6M
Q3 24
$331.0M
$553.4M
Q2 24
$356.3M
$490.7M
Net Profit
CLOV
CLOV
CNR
CNR
Q1 26
$27.3M
Q4 25
$-49.3M
$-79.0M
Q3 25
$-24.4M
$31.6M
Q2 25
$-10.6M
$-36.6M
Q1 25
$-1.3M
$-69.3M
Q4 24
$-22.1M
$30.8M
Q3 24
$-9.2M
$95.6M
Q2 24
$7.4M
$58.1M
Gross Margin
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
CNR
CNR
Q1 26
3.6%
Q4 25
-10.1%
-9.3%
Q3 25
-4.9%
-1.2%
Q2 25
-2.2%
-1.7%
Q1 25
-0.3%
-5.3%
Q4 24
-6.4%
6.6%
Q3 24
-2.7%
21.2%
Q2 24
2.0%
14.6%
Net Margin
CLOV
CLOV
CNR
CNR
Q1 26
3.6%
Q4 25
-10.1%
-7.6%
Q3 25
-4.9%
3.2%
Q2 25
-2.2%
-3.3%
Q1 25
-0.3%
-6.8%
Q4 24
-6.6%
5.4%
Q3 24
-2.8%
17.3%
Q2 24
2.1%
11.8%
EPS (diluted)
CLOV
CLOV
CNR
CNR
Q1 26
$0.05
Q4 25
$-1.51
Q3 25
$0.61
Q2 25
$-0.70
Q1 25
$-1.38
Q4 24
$1.04
Q3 24
$3.22
Q2 24
$1.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
CNR
CNR
Cash + ST InvestmentsLiquidity on hand
$177.6M
$432.2M
Total DebtLower is stronger
$354.2M
Stockholders' EquityBook value
$339.4M
$3.7B
Total Assets
$697.7M
$6.1B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
CNR
CNR
Q1 26
$177.6M
Q4 25
$78.3M
$432.2M
Q3 25
$444.7M
Q2 25
$413.2M
Q1 25
$388.5M
Q4 24
$194.5M
$460.2M
Q3 24
$288.0M
$331.7M
Q2 24
$254.8M
$216.1M
Total Debt
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
$354.2M
Q3 25
$334.5M
Q2 25
$334.0M
Q1 25
$329.8M
Q4 24
$94.8M
Q3 24
$83.7M
Q2 24
$184.9M
Stockholders' Equity
CLOV
CLOV
CNR
CNR
Q1 26
$339.4M
Q4 25
$308.7M
$3.7B
Q3 25
$340.9M
$3.8B
Q2 25
$344.2M
$3.8B
Q1 25
$336.1M
$3.9B
Q4 24
$341.1M
$1.6B
Q3 24
$342.2M
$1.5B
Q2 24
$324.9M
$1.4B
Total Assets
CLOV
CLOV
CNR
CNR
Q1 26
$697.7M
Q4 25
$541.0M
$6.1B
Q3 25
$559.7M
$6.2B
Q2 25
$575.0M
$6.2B
Q1 25
$583.7M
$6.3B
Q4 24
$580.7M
$2.9B
Q3 24
$653.0M
$2.8B
Q2 24
$674.2M
$2.7B
Debt / Equity
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
0.10×
Q3 25
0.09×
Q2 25
0.09×
Q1 25
0.08×
Q4 24
0.06×
Q3 24
0.05×
Q2 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
CNR
CNR
Operating Cash FlowLast quarter
$107.3M
Free Cash FlowOCF − Capex
$26.0M
FCF MarginFCF / Revenue
2.5%
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
$-66.9M
$107.3M
Q3 25
$12.1M
$87.9M
Q2 25
$5.4M
$220.2M
Q1 25
$-16.3M
$-109.6M
Q4 24
$34.8M
$121.3M
Q3 24
$50.0M
$161.3M
Q2 24
$44.8M
$116.3M
Free Cash Flow
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
$-69.0M
$26.0M
Q3 25
$11.4M
$38.6M
Q2 25
$4.8M
$131.0M
Q1 25
$-16.5M
$-174.5M
Q4 24
$33.3M
$80.5M
Q3 24
$49.6M
$121.9M
Q2 24
$44.4M
$60.9M
FCF Margin
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
-14.1%
2.5%
Q3 25
2.3%
3.9%
Q2 25
1.0%
11.9%
Q1 25
-3.6%
-17.1%
Q4 24
9.9%
14.0%
Q3 24
15.0%
22.0%
Q2 24
12.5%
12.4%
Capex Intensity
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
0.4%
7.8%
Q3 25
0.1%
4.9%
Q2 25
0.1%
8.1%
Q1 25
0.0%
6.4%
Q4 24
0.5%
7.1%
Q3 24
0.1%
7.1%
Q2 24
0.1%
11.3%
Cash Conversion
CLOV
CLOV
CNR
CNR
Q1 26
Q4 25
Q3 25
2.78×
Q2 25
Q1 25
Q4 24
3.94×
Q3 24
1.69×
Q2 24
6.04×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

CNR
CNR

Other$397.4M38%
Power Generation$376.5M36%
PRB$183.0M18%
Metallurgical$42.0M4%
Industrial$34.1M3%
Terminal Revenue$6.4M1%
Other Revenue$3.0M0%

Related Comparisons